PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-4.26%
Negative revenue growth while FSLR stands at 26.28%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
22.85%
Gross profit growth at 50-75% of FSLR's 35.24%. Martin Whitman would question if cost structure or brand is lagging.
64.97%
EBIT growth similar to FSLR's 62.04%. Walter Schloss might infer both firms share similar operational efficiencies.
64.97%
Operating income growth similar to FSLR's 62.04%. Walter Schloss would assume both share comparable operational structures.
-42.17%
Negative net income growth while FSLR stands at 36.58%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-48.00%
Negative EPS growth while FSLR is at 37.70%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-42.80%
Negative diluted EPS growth while FSLR is at 39.66%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-2.93%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-1.67%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
No Data
No Data available this quarter, please select a different quarter.
250.43%
OCF growth above 1.5x FSLR's 23.23%. David Dodd would confirm a clear edge in underlying cash generation.
86.11%
Positive FCF growth while FSLR is negative. John Neff would see a strong competitive edge in net cash generation.
3606.18%
Similar 10Y revenue/share CAGR to FSLR's 3335.40%. Walter Schloss might see both firms benefiting from the same long-term demand.
3606.18%
5Y revenue/share CAGR similar to FSLR's 3335.40%. Walter Schloss might see both companies benefiting from the same mid-term trends.
3606.18%
3Y revenue/share CAGR similar to FSLR's 3335.40%. Walter Schloss would assume both companies experience comparable short-term cycles.
1285.43%
OCF/share CAGR of 1285.43% while FSLR is zero. Bruce Berkowitz might see a slight advantage that could compound over time.
1285.43%
OCF/share CAGR of 1285.43% while FSLR is zero. Bruce Berkowitz would see if modest momentum can translate into a bigger competitive lead.
1285.43%
3Y OCF/share CAGR of 1285.43% while FSLR is zero. Bruce Berkowitz might see if small gains can expand into a broader advantage.
145.49%
Below 50% of FSLR's 967.13%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
145.49%
Below 50% of FSLR's 967.13%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
145.49%
Below 50% of FSLR's 967.13%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
8.42%
AR growth well above FSLR's 0.11%. Michael Burry fears inflated revenue or higher default risk in the near future.
40.59%
Inventory growth well above FSLR's 26.08%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
7.61%
Asset growth well under 50% of FSLR's 16.49%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
5.78%
Under 50% of FSLR's 13.32%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
No Data
No Data available this quarter, please select a different quarter.
-149.74%
Our R&D shrinks while FSLR invests at 15.00%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
15.74%
We expand SG&A while FSLR cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.